Showing results (1-10 of 69) with videos related to
Sort By:
Pageof 7
Leukemia & Lymphoma|June 25, 2011
Primary anaplastic large-cell lymphoma associated with breast implantsLeslie Popplewell, Sandra H Thomas, Qin Huang, et al.Genes, Chromosomes & Cancer|March 29, 2002
21q22 balanced chromosome aberrations in therapy-related hematopoietic disorders: report from an international workshopMarilyn L Slovak, Victoria Bedell, Leslie Popplewell, et al.American Journal of Clinical Pathology|February 28, 2002
Therapy-related acute myeloid leukemia/myelodysplasia with balanced 21q22 translocationsDaniel A Arber, Marilyn L Slovak, Leslie Popplewell, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 10, 2012
Functional status and health-related quality of life among allogeneic transplant patients at hospital discharge: a comparison of sociodemographic, disease, and treatment characteristicsMarcia Grant, Liz Cooke, Anna Cathy Williams, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 23, 2010
Antitransgene rejection responses contribute to attenuated persistence of adoptively transferred CD20/CD19-specific chimeric antigen receptor redirected T cells in humansMichael C Jensen, Leslie Popplewell, Laurence J Cooper, et al.CA: a Cancer Journal for Clinicians|September 14, 2012
Oral complications of cancer and cancer therapy: from cancer treatment to survivorshipJoel B Epstein, Juliette Thariat, Rene-Jean Bensadoun, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 1, 2006
Targeted total marrow irradiation using three-dimensional image-guided tomographic intensity-modulated radiation therapy: an alternative to standard total body irradiationJeffrey Y C Wong, An Liu, Timothy Schultheiss, et al.Annals of Hematology|January 7, 2011
Reduced intensity allogeneic hematopoietic cell transplantation can induce durable remission in heavily pretreated relapsed Hodgkin lymphomaRobert Chen, Joycelynne M Palmer, Leslie Popplewell, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 23, 2011
High-dose therapy and autologous hematopoietic cell transplantation in peripheral T cell lymphoma (PTCL): analysis of prognostic factorsAuayporn Nademanee, Joycelynne M Palmer, Leslie Popplewell, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 11, 2014
Brentuximab vedotin is associated with improved progression-free survival after allogeneic transplantation for Hodgkin lymphomaRobert Chen, Joycelynne M Palmer, Ni-Chun Tsai, et al.Pageof 7